Clinical trial · Interventional
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
NCT05046262CI-TRIAL-00053887unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Calcium chloride | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- complete response
- timeFrame
- 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Primary low risk basal cell carcinoma less than 3 cm in diameter \- Exclusion Criteria: Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics
References
Publications (0)
Data not yet available
No reference posted for this study.